Head and Neck Cancers Coverage from Every Angle
Advertisement
Advertisement

Recent News

Head/Neck Cancers Symposium 2020: Psychosocial Screening May Reduce Distress in Patients With Head & Neck Cancer
Head/Neck Cancers Symposium 2020: Concurrent Chemoradiotherapy Plus Bevacizumab
TAT 2020: ICOS Receptor Agonist in Head/Neck Squamous Cell Cancer
Head/Neck Cancers Symposium 2020: Addition of Cetuximab to Combination Radiotherapy Plus Cisplatin
Head/Neck Cancers Symposium 2020: Adjuvant Everolimus in Locally Advanced Squamous Cell Carcinoma
Head/Neck Cancers Symposium 2020: SBRT Plus Pembrolizumab in Previously Irradiated Squamous Cell Carcinoma
Head/Neck Cancers Symposium 2020: Managing Oral Mucositis After Chemoradiotherapy Without Compromising Tumor Control
Head/Neck Cancers Symposium 2020: Immunotherapy Plus Radiotherapy in Squamous Cell Carcinoma
Are Prostanoid Receptor Genes Related to Prognosis in Head/Neck Cancer?
First-in-Class Radiotracer Granted FDA Fast Track Designation in Head and Neck Cancer
Review of Current Omics-Related Literature for Patients With Head/Neck Cancer
Matching Tumor Mutations to Treatment for Salivary Gland Cancer
Testing for HPV in Patients With Sinonasal Squamous Cell Carcinoma
NCI-MATCH Trial Subprotocol: T-DM1 in HER2-Positive Salivary Gland Tumors
HPV Status May Influence Mortality Rates in Patients With Oropharyngeal Cancer
KEYNOTE-048 Opens Door Farther for Pembrolizumab in Head/Neck Cancer
PDK1 Inhibition and Resistance to Cetuximab in Head/Neck Squamous Cell Carcinoma
RSNA 2019: Brachytherapy for Elderly Patients With Skin Cancer of the Head/Neck
Late Cranial Neuropathy in Survivors of Head and Neck Cancer
Patients With Head/Neck Cancer Prefer Dietary Counseling Before Treatment, Study Finds
Triple Metronomic Chemotherapy for Platinum-Refractory Oral Cancer
Connecting LncRNA Molecule to Development of Head/Neck Squamous Cell Carcinoma
Tipifarnib in HRAS-Mutant Head/Neck Squamous Cell Carcinomas
Personalization of Treatment Based on Fitness in Elderly Patients With Head/Neck Cancer
Study Identifies Risk Factors for Head/Neck Cancer in World Trade Center Responders
ESMO 2019: Monalizumab Monotherapy for Resistant Head/Neck Cancer
ESMO 2019: Locoregional Radiotherapy Plus Chemotherapy for Nasopharyngeal Carcinoma
ASTRO 2019: Adding Cisplatin to Radiation Therapy in Advanced Oropharyngeal Cancer
Advertisement
Advertisement


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.